Thumbnail Image
Publication

Possible modification of BRSK1 on the risk of alkylating chemotherapy-related reduced ovarian function.

van der Kooi, Anne-Lotte L F
; 
van Dijk, Marloes
; 
Broer, Linda
; 
van den Berg, Marleen H
; 
Laven, Joop S E
; 
van Leeuwen, Flora E
; 
Lambalk, Cornelis B
; 
Overbeek, Annelies
; 
Loonen, Jacqueline J
; 
van der Pal, Helena J
... show 10 more
Citations
Google Scholar:
Lookup
Altmetric:
Author
van der Kooi, Anne-Lotte L F
 van Dijk, Marloes
 Broer, Linda
 van den Berg, Marleen H
 Laven, Joop S E
 van Leeuwen, Flora E
 Lambalk, Cornelis B
 Overbeek, Annelies
 Loonen, Jacqueline J
 van der Pal, Helena J
 Tissing, Wim J
 Versluys, Birgitta
 Bresters, Dorine
 Beerendonk, Catharina C M
 Ronckers, Cécile R
 van der Heiden-van der Loo, Margriet
 Kaspers, Gertjan L
 de Vries, Andrica C H
 Robison, Leslie L
 Hudson, Melissa M
 Chemaitilly, Wassim
 Byrne, Julianne
 Berger, Claire
 Clemens, Eva
 Dirksen, Uta
 Falck Winther, Jeanette
 Fosså, Sophie D
 Grabow, Desiree
 Haupt, Riccardo
 Kaiser, Melanie
 Kepak, Tomas
 Kruseova, Jarmila
 Modan-Moses, Dalit
 Pluijm, Saskia M F
 Spix, Claudia
 Zolk, Oliver
 Kaatsch, Peter
 Krijthe, Jesse H
 Kremer, Leontien C
 Yasui, Yutaka
 Brooke, Russell J
 Uitterlinden, André G
 van den Heuvel-Eibrink, Marry M
 van Dulmen-den Broeder, Eline
Advisors
Editors
Other Contributors
Departments
Boyne Research Institute
Date
2021-02-14
Date Submitted
Keywords
childhood cancer
FERTILITY
gonadotoxicity
ovarian reserve
survivorship
Other Subjects
Subject Mesh
Planned Date
Start Date
Collaborators
Principal Investigators
Files
Thumbnail Image
deaa342.pdf
Adobe PDF, 310.72 KB
Alternative Titles
Publisher
URI
https://hdl.handle.net/10147/633399
Abstract
Language
en
Citation
ISSN
eISSN
1460-2350
ISBN
DOI
10.1093/humrep/deaa342
PMID
33582778
PMCID
Sponsorships
Funding Sources
Funding Amounts
Grant Identifiers
Methodology
Duration
Ethical Approval
Embedded videos